Appraisal in progress
Indication |
|
| Status: In progress | |
Treatment of severe, chronic pain in adults who require intrathecal (IT) analgesia. |
|
Medicine details |
|
| Medicine name | ziconotide (Prialt®) |
| Formulation | 100 micrograms in 1 ml vial, 500 micrograms in 20 ml vial |
| Reference number | 5385 |
| Indication | Treatment of severe, chronic pain in adults who require intrathecal (IT) analgesia |
| Company | Esteve Limited |
| BNF chapter | Central nervous system |
| Submission type | Full |
| Status | In progress |
| NMG meeting date | 20/03/2025 |
| AWMSG meeting date | 20/05/2025 |
| Commercial arrangement | PAS |